Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueDividends payablesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Strategy (STRF) Cash & Equivalents (2016 - 2025)

Strategy's Cash & Equivalents history spans 16 years, with the latest figure at $2.3 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 5937.91% year-over-year to $2.3 billion; the TTM value through Dec 2025 reached $2.3 billion, up 5937.91%, while the annual FY2025 figure was $2.3 billion, 5937.91% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $2.3 billion at Strategy, up from $1.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.3 billion in Q4 2025 and bottomed at $1.2 million in Q2 2021.
  • The 5-year median for Cash & Equivalents is $22.3 million (2022), against an average of $145.7 million.
  • The largest annual shift saw Cash & Equivalents crashed 97.68% in 2023 before it surged 5937.91% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $63.4 million in 2021, then tumbled by 30.81% to $43.8 million in 2022, then tumbled by 95.77% to $1.9 million in 2023, then soared by 1953.72% to $38.1 million in 2024, then soared by 5937.91% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for STRF's Cash & Equivalents are $2.3 billion (Q4 2025), $1.9 million (Q3 2025), and $2.0 million (Q2 2025).